ENO1 and neoplasm: Subsequent subcutaneous injection or orthotopic tumor model of immunocompetent mice with WT or ENO1-KO cells demonstrated that the absence of ENO1 in the tumor cells significantly inhibited tumorigenesis, as evidenced by reduced tumor volume, weight, as well as the survival rate in the ENO1-KO group (Fig. 2A-H).